| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.22 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.055 | 0.3 |